HRL
Hormel Foods Corporation NYSE Listed Mar 17, 1980$20.75
Mkt Cap $11.4B
52w Low $20.32
3.7% of range
52w High $31.86
50d MA $22.35
200d MA $24.16
P/E (TTM)
24.5x
EV/EBITDA
15.2x
P/B
1.5x
Debt/Equity
0.4x
ROE
6.2%
P/FCF
24.4x
RSI (14)
—
ATR (14)
—
Beta
0.36
50d MA
$22.35
200d MA
$24.16
Avg Volume
4.8M
Hormel Foods Corporation develops, processes, and distributes various meat, nuts, and food products to retail, foodservice, deli, and commercial customers in the United States and internationally. The company operates through four segments: Grocery Products, Refrigerated Foods, Jennie-O Turkey Store, and International & Other. It provides various perishable products that include fresh meats, frozen items, refrigerated meal solutions, sausages, hams, guacamoles, and bacons; and shelf-stable products comprising canned luncheon meats, nut butters, snack nuts, chilies, shelf-stable microwaveable meals, hashes, stews, tortillas, salsas, tortilla chips, and others. The company also engages in the processing, marketing, and sale of branded and unbranded pork, beef, poultry, and turkey products, as well as offers nutritional food products and supplements, desserts and drink mixes, and industrial gelatin products. It sells its products primarily under the SKIPPY, SPAM, Hormel, Natural Choice, Applegate, Justin's, Jennie-O, Café H, Herdez, Black Label, Sadler's, Columbus, Gatherings, Herdez, Wholly, Columbus, Planters, NUT-rition, Planters Cheez Balls, Corn Nuts, etc. brand names through sales personnel, independent brokers, and distributors. The company was formerly known as Geo. A. Hormel & Company and changed its name to Hormel Foods Corporation in January 1995. Hormel Foods Corporation was founded in 1891 and is headquartered in Austin, Minnesota.
1 Hormel Place · Austin, MN 55912-3680 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 26, 2026 | AMC | 0.32 | 0.34 | +6.2% | 24.82 | +0.2% | +3.1% | +0.0% | -0.9% | -1.5% | -2.5% | — |
| Dec 4, 2025 | AMC | 0.30 | 0.32 | +6.1% | 24.16 | +0.3% | +0.7% | -1.3% | -2.2% | -1.7% | -1.9% | — |
| Aug 28, 2025 | AMC | 0.40 | 0.35 | -12.8% | 25.22 | +0.1% | +0.9% | -0.8% | +0.5% | +0.1% | +1.7% | — |
| May 29, 2025 | AMC | 0.34 | 0.35 | +2.4% | 30.38 | +0.5% | +1.0% | +1.5% | +1.5% | +1.1% | +1.1% | — |
| Feb 27, 2025 | AMC | 0.38 | 0.35 | -7.0% | 28.38 | +1.0% | +0.9% | +3.9% | +1.8% | +1.3% | +2.2% | — |
| Dec 4, 2024 | AMC | 0.43 | 0.42 | -2.3% | 31.99 | +0.5% | +2.7% | +1.5% | +3.7% | +4.9% | +3.6% | — |
| Sep 4, 2024 | AMC | 0.36 | 0.37 | +2.8% | 31.01 | +1.1% | +3.5% | +5.0% | +4.5% | +3.9% | +1.1% | — |
| May 30, 2024 | AMC | 0.36 | 0.38 | +5.6% | 30.79 | -0.3% | +0.6% | +0.4% | -0.2% | -0.6% | +0.3% | — |
| Feb 29, 2024 | AMC | 0.33 | 0.41 | +24.2% | 35.32 | +0.0% | -5.5% | -4.4% | -3.7% | -3.2% | -3.8% | — |
| Nov 29, 2023 | AMC | 0.44 | 0.42 | -4.5% | 30.47 | +0.1% | +0.4% | +2.8% | +4.2% | +2.9% | +4.7% | — |
| Aug 31, 2023 | AMC | 0.41 | 0.40 | -2.4% | 38.59 | -0.4% | -0.5% | -2.4% | -3.5% | -4.2% | -3.8% | — |
| Jun 1, 2023 | AMC | 0.40 | 0.40 | +0.0% | 40.20 | +0.2% | +1.4% | +0.9% | +0.6% | +0.4% | +1.1% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 9 | JP Morgan | Downgrade | Overweight → Neutral | — | $21.64 | $21.05 | -2.7% | -2.4% | -3.6% | -5.4% | -4.1% | -4.5% |
| Feb 27 | Stephens & Co. | Maintains | Equal Weight → Equal Weight | — | $24.82 | $24.87 | +0.2% | +3.1% | +0.0% | -0.9% | -1.5% | -2.5% |
| Feb 11 | Stephens & Co. | Maintains | Equal Weight → Equal Weight | — | $24.30 | $24.01 | -1.2% | -1.4% | -3.5% | -2.1% | -3.5% | +0.7% |
| Dec 9 | Barclays | Maintains | Overweight → Overweight | — | $23.85 | $23.85 | +0.0% | -0.9% | -0.5% | -0.6% | +0.8% | +0.6% |
| Dec 5 | Piper Sandler | Maintains | Neutral → Neutral | — | $24.16 | $24.23 | +0.3% | +0.7% | -1.3% | -2.2% | -1.7% | -1.9% |
| Dec 5 | BofA Securities | Maintains | Neutral → Neutral | — | $24.16 | $24.23 | +0.3% | +0.7% | -1.3% | -2.2% | -1.7% | -1.9% |
| Dec 5 | JP Morgan | Maintains | Overweight → Overweight | — | $24.16 | $24.23 | +0.3% | +0.7% | -1.3% | -2.2% | -1.7% | -1.9% |
| Nov 21 | JP Morgan | Maintains | Overweight → Overweight | — | $22.32 | $22.47 | +0.7% | +1.7% | +1.3% | +3.0% | +4.1% | +4.0% |
| Nov 6 | Piper Sandler | Maintains | Neutral → Neutral | — | $21.55 | $21.58 | +0.1% | +0.8% | +2.2% | +2.8% | +4.5% | +3.3% |
| Oct 30 | Goldman Sachs | Maintains | Buy → Buy | — | $21.49 | $21.57 | +0.4% | -0.9% | +0.5% | -0.0% | +0.4% | +0.3% |
| Aug 29 | Barclays | Maintains | Overweight → Overweight | — | $25.22 | $25.25 | +0.1% | +0.9% | -0.8% | +0.5% | +0.1% | +1.7% |
| Aug 29 | Goldman Sachs | Maintains | Buy → Buy | — | $25.22 | $25.25 | +0.1% | +0.9% | -0.8% | +0.5% | +0.1% | +1.7% |
| Aug 29 | BofA Securities | Maintains | Neutral → Neutral | — | $25.22 | $25.25 | +0.1% | +0.9% | -0.8% | +0.5% | +0.1% | +1.7% |
| Aug 29 | JP Morgan | Maintains | Overweight → Overweight | — | $25.22 | $25.25 | +0.1% | +0.9% | -0.8% | +0.5% | +0.1% | +1.7% |
| Aug 20 | JP Morgan | Upgrade | Neutral → Overweight | — | $28.41 | $29.00 | +2.1% | +0.8% | +1.8% | +3.0% | +1.6% | +1.2% |
| May 22 | Stephens & Co. | Maintains | Equal Weight → Equal Weight | — | $29.42 | $29.29 | -0.4% | +0.1% | +0.1% | +2.7% | +2.1% | +3.3% |
| Apr 15 | BofA Securities | Upgrade | Underperform → Neutral | — | $30.55 | $30.97 | +1.4% | -0.6% | -1.2% | +0.1% | -0.5% | +0.5% |
| Feb 18 | Stephens & Co. | Maintains | Equal Weight → Equal Weight | — | $28.46 | $28.35 | -0.4% | -0.6% | +0.4% | +1.4% | +4.2% | +2.7% |
| Jan 22 | Barclays | Upgrade | Equal Weight → Overweight | — | $30.86 | $30.89 | +0.1% | -1.7% | +0.0% | +0.1% | +1.9% | -1.3% |
| Jan 21 | Barclays | Maintains | Equal Weight → Equal Weight | — | $29.93 | $29.91 | -0.1% | +3.1% | +1.4% | +3.1% | +3.2% | +5.1% |
| Nov 19 | Citigroup | Maintains | Buy → Buy | — | $29.40 | $29.15 | -0.9% | +1.1% | +2.8% | +3.7% | +4.3% | +6.9% |
| Aug 13 | Citigroup | Upgrade | Neutral → Buy | — | $31.25 | $32.40 | +3.7% | +1.8% | +3.2% | +2.5% | +3.6% | +4.6% |
| May 31 | Stephens & Co. | Maintains | Equal Weight → Equal Weight | — | $30.79 | $30.71 | -0.3% | +0.6% | +0.4% | -0.2% | -0.6% | +0.3% |
| May 31 | JP Morgan | Upgrade | Underweight → Neutral | — | $30.79 | $30.71 | -0.3% | +0.6% | +0.4% | -0.2% | -0.6% | +0.3% |
| May 31 | Citigroup | Maintains | Neutral → Neutral | — | $30.79 | $30.71 | -0.3% | +0.6% | +0.4% | -0.2% | -0.6% | +0.3% |
| Mar 1 | Goldman Sachs | Maintains | Sell → Sell | — | $35.32 | $35.32 | +0.0% | -5.5% | -4.4% | -3.7% | -3.2% | -3.8% |
| Mar 1 | Barclays | Maintains | Equal Weight → Equal Weight | — | $35.32 | $35.32 | +0.0% | -5.5% | -4.4% | -3.7% | -3.2% | -3.8% |
| Mar 1 | JP Morgan | Maintains | Underweight → Underweight | — | $35.32 | $35.32 | +0.0% | -5.5% | -4.4% | -3.7% | -3.2% | -3.8% |
| Jan 12 | Piper Sandler | Maintains | Neutral → Neutral | — | $31.77 | $31.68 | -0.3% | +0.1% | -1.4% | -1.8% | -2.2% | -3.6% |
| Nov 30 | Goldman Sachs | Maintains | Sell → Sell | — | $30.47 | $30.50 | +0.1% | +0.4% | +2.8% | +4.2% | +2.9% | +4.7% |
| Oct 16 | JP Morgan | Maintains | Underweight → Underweight | — | $32.02 | $32.05 | +0.1% | +0.3% | +1.2% | -0.5% | -0.6% | -1.9% |
| Oct 13 | Goldman Sachs | Maintains | Sell → Sell | — | $32.67 | $32.09 | -1.8% | -2.0% | -1.7% | -0.8% | -2.5% | -2.6% |
| Oct 13 | Piper Sandler | Maintains | Neutral → Neutral | — | $32.67 | $32.09 | -1.8% | -2.0% | -1.7% | -0.8% | -2.5% | -2.6% |
| Jun 1 | Barclays | Maintains | Equal Weight → Equal Weight | — | $38.25 | $40.15 | +5.0% | +5.1% | +6.6% | +6.0% | +5.7% | +5.5% |
| Apr 12 | Piper Sandler | Maintains | Neutral → Neutral | — | $40.34 | $40.21 | -0.3% | -0.3% | -0.5% | -2.7% | -1.3% | -1.5% |
| Mar 30 | Argus | Downgrade | Buy → Hold | — | $39.30 | $39.15 | -0.4% | -0.2% | +1.5% | +2.8% | +4.1% | +3.0% |
| Mar 6 | Stephens & Co. | Maintains | Equal Weight → Equal Weight | — | $40.63 | $40.81 | +0.4% | -0.2% | -1.6% | -1.0% | -2.2% | -3.6% |
| Mar 3 | Credit Suisse | Maintains | Neutral → Neutral | — | $41.83 | $41.00 | -2.0% | -2.9% | -3.1% | -4.4% | -3.8% | -5.0% |
| Mar 3 | JP Morgan | Downgrade | Neutral → Underweight | — | $41.83 | $41.00 | -2.0% | -2.9% | -3.1% | -4.4% | -3.8% | -5.0% |
| Dec 30 | Argus | Maintains | Buy → Buy | — | $45.51 | $45.54 | +0.1% | +0.1% | +0.5% | +0.8% | +1.2% | +3.1% |
| Dec 1 | JP Morgan | Maintains | Neutral → Neutral | — | $47.00 | $47.00 | +0.0% | +1.3% | +1.4% | +0.4% | -0.3% | +1.3% |
| Sep 22 | Argus | Maintains | Buy → Buy | — | $46.57 | $46.68 | +0.2% | +1.0% | +0.6% | +0.6% | -0.4% | +0.8% |
| Sep 2 | Piper Sandler | Maintains | Neutral → Neutral | — | $46.98 | $47.16 | +0.4% | -1.3% | -0.9% | +0.4% | -0.3% | -0.3% |
| Aug 23 | Stephens & Co. | Maintains | Equal Weight → Equal Weight | — | $50.72 | $50.66 | -0.1% | +1.1% | +1.4% | +1.4% | +0.7% | +1.1% |
| Mar 15 | Goldman Sachs | Downgrade | Neutral → Sell | — | $50.04 | $48.97 | -2.1% | -1.7% | -1.3% | -0.7% | -1.6% | -0.6% |
| Mar 10 | Argus | Upgrade | Hold → Buy | — | $49.91 | $50.12 | +0.4% | +1.1% | +1.1% | +0.3% | -1.4% | -1.1% |
| Mar 2 | Credit Suisse | Maintains | Neutral → Neutral | — | $49.54 | $49.35 | -0.4% | +1.9% | +3.9% | +4.4% | +5.4% | +1.5% |
| Mar 2 | JP Morgan | Maintains | Neutral → Neutral | — | $49.54 | $49.35 | -0.4% | +1.9% | +3.9% | +4.4% | +5.4% | +1.5% |
| Mar 2 | Piper Sandler | Maintains | Neutral → Neutral | — | $49.54 | $49.35 | -0.4% | +1.9% | +3.9% | +4.4% | +5.4% | +1.5% |
| Dec 10 | Credit Suisse | Maintains | Neutral → Neutral | — | $44.80 | $45.20 | +0.9% | +2.7% | +5.5% | +6.9% | +8.5% | +9.8% |
No insider trades available.
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
I cannot provide a meaningful analysis based on this filing excerpt, as it contains only boilerplate legal language about incorporation by reference without disclosing the actual executive change details needed to assess impact.
Apr 2
8-K
Hormel Foods Corporation -- 8-K Filing
Hormel Foods demonstrated strong quarterly performance driven by its protein portfolio and successful pricing strategies that improved profitability relative to revenue growth.
Feb 26
8-K
Hormel Foods Corporation -- 8-K Filing
Hormel Foods is divesting its whole-bird turkey business as part of strategic portfolio optimization while maintaining its fiscal 2026 organic sales and adjusted EPS guidance.
Feb 18
8-K · 5.02
!!! Very High
Hormel Foods Corporation -- 8-K 5.02: Executive Change
Hormel Foods' Chief Financial Officer Jacinth Smiley departed effective November 30, 2025, creating a leadership transition that investors should monitor for potential impacts on financial oversight and strategic direction.
Feb 13
8-K · 5.02
!!! Very High
Hormel Foods Corporation -- 8-K 5.02: Executive Change
The departure of an executive may signal internal instability or strategy shifts, potentially creating uncertainty for investors evaluating management quality and operational continuity at this food company.
Feb 2
Data updated apr 25, 2026 2:01pm
· Source: massive.com